Guang Li-KY (6431) Corrects Q1 2026 IFRS iXBRL Filing Regarding Investee Information
Guang Li-KY (6431) announced a correction to its first-quarter 2026 IFRS iXBRL filing. The correction specifically addresses the details of its investee companies, including their names, locations, business activities, investment amounts, shareholding status, and recognized investment gains or losses. The company clarified that the original filing did not contain any incorrect amounts or content, but rather an update to the presentation of this specific information was necessary. The corrected information has been re-uploaded to the public information observatory.
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 12:57
- 🔍 Collected: May 16, 2026 at 12:57 (0 min after Published)
- 🤖 AI Analyzed: May 16, 2026 at 14:46 (1h 49m after Collected)
Announcement Date: May 16, 2026
Statement Date: May 15, 2026
Statement Time: 193918
Company Code: 6431
Company Name: Guang Li-KY
Subject: Correction of the company's Q1 2026 IFRSs iXBRL announcement information
Compliance Clause: Clause 51
Date of Fact Occurrence: May 15, 2026
Explanation:
1. Date of Fact Occurrence: 115/05/15
2. Company Name: Guang Li Biotechnology Holdings Co., Ltd.
3. Relationship with Company (Enter 'Parent Company' or 'Subsidiary'): Parent Company
4. Proportion of Mutual Shareholding: Not applicable
5. Reason for Occurrence: Correction of the company's Q1 2026 IFRSs iXBRL announcement information
6. Item/Report Name Corrected:
"Investee Company Name, Location, etc. Related Information" / IFRSs iXBRL Report
7. Original Amount/Content/Page Number: No such situation / Not required to disclose
8. Corrected Amount/Content/Page Number:
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Novel Idea Co., Ltd.
Region Code: 132 / Location: Mauritius
Main Business Item: Holding Company
Original Investment Amount - End of Current Period: $188,771 / End of Last Year: $185,437
Shareholding Status at End of Period - Number of Shares: 5,900 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: ($368)
Investee Company's Profit/Loss for the Current Period: ($151)
Investment Gain/Loss Recognized in Current Period: ($151)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Taiwan Guang Li Industrial Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Health Management Business
Original Investment Amount - End of Current Period: $156,186 / End of Last Year: $126,186
Shareholding Status at End of Period - Number of Shares: 15,619 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $33,680
Investee Company's Profit/Loss for the Current Period: ($7,200)
Investment Gain/Loss Recognized in Current Period: ($7,200)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Alliance Capital Investment Management Inc.
Region Code: 226 / Location: British Virgin Islands
Main Business Item: Holding Company
Original Investment Amount - End of Current Period: $705,879 / End of Last Year: $695,382
Shareholding Status at End of Period - Number of Shares: 23 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $303,271
Investee Company's Profit/Loss for the Current Period: ($20,906)
Investment Gain/Loss Recognized in Current Period: ($25,736)
Remarks: Note 3
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Li Biotechnology Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Cosmetics, Skincare, Health Product Trading Business
Original Investment Amount - End of Current Period: $20,000 / End of Last Year: $20,000
Shareholding Status at End of Period - Number of Shares: 2,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $19,550
Investee Company's Profit/Loss for the Current Period: 572
Investment Gain/Loss Recognized in Current Period: 572
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Suan Li Intelligent Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Computer AI Hardware Sales and Information Processing Services
Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000
Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $9,498
Investee Company's Profit/Loss for the Current Period: ($275)
Investment Gain/Loss Recognized in Current Period: ($275)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Yao Medical Management Consulting Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Health Consulting Services and Health Product Trading Business
Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000
Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $9,506
Investee Company's Profit/Loss for the Current Period: ($257)
Investment Gain/Loss Recognized in Current Period: ($257)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Li International Co., Ltd.
Original Investment Amount - End of Current Period: $7,000 / End of Last Year: $7,000
Shareholding Status at End of Period - Number of Shares: 700 thousand shares
Shareholding Status at End of Period - Ratio: 70%
Shareholding Status at End of Period - Book Value: $8,016
Investee Company's Profit/Loss for the Current Period: 1,994
Investment Gain/Loss Recognized in Current Period: 1,396
9. Countermeasures: Re-upload public information to the observatory after correction.
10. Other Matters to be Noted: None.
Statement Date: May 15, 2026
Statement Time: 193918
Company Code: 6431
Company Name: Guang Li-KY
Subject: Correction of the company's Q1 2026 IFRSs iXBRL announcement information
Compliance Clause: Clause 51
Date of Fact Occurrence: May 15, 2026
Explanation:
1. Date of Fact Occurrence: 115/05/15
2. Company Name: Guang Li Biotechnology Holdings Co., Ltd.
3. Relationship with Company (Enter 'Parent Company' or 'Subsidiary'): Parent Company
4. Proportion of Mutual Shareholding: Not applicable
5. Reason for Occurrence: Correction of the company's Q1 2026 IFRSs iXBRL announcement information
6. Item/Report Name Corrected:
"Investee Company Name, Location, etc. Related Information" / IFRSs iXBRL Report
7. Original Amount/Content/Page Number: No such situation / Not required to disclose
8. Corrected Amount/Content/Page Number:
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Novel Idea Co., Ltd.
Region Code: 132 / Location: Mauritius
Main Business Item: Holding Company
Original Investment Amount - End of Current Period: $188,771 / End of Last Year: $185,437
Shareholding Status at End of Period - Number of Shares: 5,900 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: ($368)
Investee Company's Profit/Loss for the Current Period: ($151)
Investment Gain/Loss Recognized in Current Period: ($151)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Taiwan Guang Li Industrial Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Health Management Business
Original Investment Amount - End of Current Period: $156,186 / End of Last Year: $126,186
Shareholding Status at End of Period - Number of Shares: 15,619 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $33,680
Investee Company's Profit/Loss for the Current Period: ($7,200)
Investment Gain/Loss Recognized in Current Period: ($7,200)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Alliance Capital Investment Management Inc.
Region Code: 226 / Location: British Virgin Islands
Main Business Item: Holding Company
Original Investment Amount - End of Current Period: $705,879 / End of Last Year: $695,382
Shareholding Status at End of Period - Number of Shares: 23 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $303,271
Investee Company's Profit/Loss for the Current Period: ($20,906)
Investment Gain/Loss Recognized in Current Period: ($25,736)
Remarks: Note 3
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Li Biotechnology Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Cosmetics, Skincare, Health Product Trading Business
Original Investment Amount - End of Current Period: $20,000 / End of Last Year: $20,000
Shareholding Status at End of Period - Number of Shares: 2,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $19,550
Investee Company's Profit/Loss for the Current Period: 572
Investment Gain/Loss Recognized in Current Period: 572
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Suan Li Intelligent Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Computer AI Hardware Sales and Information Processing Services
Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000
Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $9,498
Investee Company's Profit/Loss for the Current Period: ($275)
Investment Gain/Loss Recognized in Current Period: ($275)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Yao Medical Management Consulting Co., Ltd.
Region Code: 0 / Location: Taiwan
Main Business Item: Health Consulting Services and Health Product Trading Business
Original Investment Amount - End of Current Period: $10,000 / End of Last Year: $10,000
Shareholding Status at End of Period - Number of Shares: 1,000 thousand shares
Shareholding Status at End of Period - Ratio: 100%
Shareholding Status at End of Period - Book Value: $9,506
Investee Company's Profit/Loss for the Current Period: ($257)
Investment Gain/Loss Recognized in Current Period: ($257)
-----------------------------------------------------------
IFRSs iXBRL "Investee Company Name, Location, etc. Related Information"
Investing Company: Parent Company / Investee Company: Chen Li International Co., Ltd.
Original Investment Amount - End of Current Period: $7,000 / End of Last Year: $7,000
Shareholding Status at End of Period - Number of Shares: 700 thousand shares
Shareholding Status at End of Period - Ratio: 70%
Shareholding Status at End of Period - Book Value: $8,016
Investee Company's Profit/Loss for the Current Period: 1,994
Investment Gain/Loss Recognized in Current Period: 1,396
9. Countermeasures: Re-upload public information to the observatory after correction.
10. Other Matters to be Noted: None.
FAQ
What is the purpose of this announcement?
The announcement is to correct previously filed IFRS iXBRL information for Guang Li-KY's first quarter of 2026.
What specific information was corrected?
The correction pertains to details of investee companies, such as their names, locations, business types, investment amounts, shareholding percentages, and the recognized investment gains or losses.
Were there any financial errors in the original filing?
The announcement states that there were no incorrect amounts or content in the original filing; the correction was related to the presentation of information regarding investee companies.
Which investee companies are mentioned in the corrected filing?
The corrected filing includes information on Novel Idea Co., Ltd. (Mauritius), Taiwan Guang Li Industrial Co., Ltd. (Taiwan), Alliance Capital Investment Management Inc. (British Virgin Islands), Chen Li Biotechnology Co., Ltd. (Taiwan), Suan Li Intelligent Co., Ltd. (Taiwan), Chen Yao Medical Management Consulting Co., Ltd. (Taiwan), and Chen Li International Co., Ltd. (Taiwan).
What is the company code for Guang Li?
The company code for Guang Li-KY is 6431.